+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mirabegron Sustained-release Tablets Market - Global Forecast 2025-2030- Product Image
Mirabegron Sustained-release Tablets Market - Global Forecast 2025-2030- Product Image
Sale

Mirabegron Sustained-release Tablets Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6130302
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The market for Mirabegron sustained-release tablets is rapidly evolving, shaped by changing clinical needs and innovative delivery technologies. Senior decision-makers face intensifying pressure to navigate a sector characterized by shifting regulatory frameworks, emerging competition, and new approaches to drug adherence and supply chain optimization.

Market Snapshot: Mirabegron Sustained-Release Tablets

Driven by the increasing prevalence of overactive bladder and rising demand for patient-centric solutions, the Mirabegron sustained-release tablets market demonstrates strong growth dynamics. Sustained-release formulations extend pharmacokinetic profiles and address both symptom control and adherence, capturing expanded patient segments across mature and emerging regions. Notably, established payer systems in the Americas and advanced healthcare infrastructures in the Asia-Pacific region fuel consistent adoption rates.

Scope & Segmentation of the Mirabegron Sustained-Release Tablets Market

This report provides a comprehensive outlook across all significant segments, geographies, and operational structures in the Mirabegron sustained-release space.

  • Dosage Strength: Options include 25 mg initiation tablets and 50 mg formulations for patients requiring enhanced symptom management.
  • Product Type: The market structure incorporates both generic and original branded sustained-release Mirabegron tablets.
  • Distribution Channel: Mapping highlights hospital pharmacies, online pharmacies, chain pharmacies, and independent pharmacies as core access points.
  • End User: Key users are clinics, home care providers, private and public hospitals.
  • Indication: Segmentation encompasses overactive bladder management and targeted urge incontinence therapy.
  • Geographic Coverage: Analysis includes the Americas (United States with state-level granularity, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, and selected other markets), and Asia-Pacific (China, India, Japan, Australia, and others).
  • Manufacturers Profiled: Companies analyzed include Astellas Pharma Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz International GmbH, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, and Torrent Pharmaceuticals Ltd.

Key Takeaways for Decision-Makers

  • The demand for Mirabegron sustained-release tablets remains supported by an aging global population and evolving clinical expectations. Extended-release formulations strengthen adherence by minimizing dosing frequency and smoothing plasma concentrations.
  • Digital health integrations such as adherence-tracking applications and smart pill dispensers foster real-time monitoring, enhancing patient outcomes and supporting value-based care approaches.
  • Brand-originator tablets retain a strategic position in formularies due to robust long-term safety and efficacy data, while generic alternatives increasingly compete on pricing and market access, particularly in cost-sensitive channels.
  • Strategic collaborations, notably between pharmaceutical manufacturers and contract development organizations, are accelerating next-generation formulation development, driving differentiation and supply chain agility amid regulatory shifts.
  • Regional adoption patterns reveal that advanced reimbursement frameworks in developed markets and government-driven integration in emerging countries jointly propel access, though local regulatory landscapes and infrastructure variations introduce nuanced barriers and opportunities.

Tariff Impact on Mirabegron Sustained-Release Tablets in 2025

The 2025 introduction of new United States import tariffs imposed cost pressures on the pharmaceutical supply chain, notably influencing active pharmaceutical ingredient sourcing for Mirabegron sustained-release tablets. Contract manufacturers and production facilities responded by renegotiating supplier agreements and increasing local sourcing efforts. Distribution networks faced rising transportation and warehousing costs, leading to revised pricing strategies with healthcare providers. These tariff adjustments prompted industry leaders to streamline manufacturing operations and seek trade relief, while collaborative industry-government initiatives have begun to address supply constraints and protect patient access.

Mirabegron Sustained-Release Tablets: Methodology & Data Sources

This report applies a mixed-method approach, drawing on primary interviews with urology leaders, formulary managers, supply chain executives, and contract development partners. Secondary sources include peer-reviewed publications, regulatory filings, corporate reports, and digital health registries. Analytical tools such as Porter’s Five Forces and SWOT analysis, alongside data triangulation, ensure sophisticated and reliable insight.

Why This Report Matters for Industry Leaders

  • Gain clarity on evolving demand drivers, including adherence strategies, patient-centric design, and supply chain adaptations.
  • Identify competitive advantages in brand and generic positioning, leveraging insights for portfolio development and strategic investments.
  • Understand regional and channel-specific nuances that inform risk mitigation and future market entry decisions.

Conclusion

Mirabegron sustained-release tablets are reshaping urological care with innovations in formulation, access, and adherence. Decision-makers equipped with this research can confidently anticipate market shifts, target investment, and sustain strategic growth in a dynamic specialty pharmaceutical environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of once-daily sustained-release mirabegron tablets among overactive bladder patients seeking improved compliance and tolerability
5.2. Rising investment in real-world evidence studies to demonstrate long-term safety and efficacy of mirabegron sustained-release formulations in diverse patient populations
5.3. Growing interest in combination therapies pairing mirabegron sustained-release tablets with antimuscarinic agents to enhance symptom control in refractory OAB cases
5.4. Expanding biosimilar competition for mirabegron sustained-release tablets driving price erosion and prompting differentiation through patient support programs
5.5. Regulatory approvals and label expansions for mirabegron sustained-release formulations targeting male urinary storage symptoms and benign prostatic hyperplasia patients
5.6. Development of novel extended-release matrix technologies aimed at optimizing mirabegron plasma profiles and reducing peak-trough fluctuations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mirabegron Sustained-release Tablets Market, by Dosage Strength
8.1. Introduction
8.2. 25 Mg
8.3. 50 Mg
9. Mirabegron Sustained-release Tablets Market, by Product Type
9.1. Introduction
9.2. Generic
9.3. Original
10. Mirabegron Sustained-release Tablets Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Mirabegron Sustained-release Tablets Market, by End User
11.1. Introduction
11.2. Clinic
11.3. Home Care
11.4. Hospital
11.4.1. Private Hospital
11.4.2. Public Hospital
12. Mirabegron Sustained-release Tablets Market, by Indication
12.1. Introduction
12.2. Overactive Bladder
12.3. Urge Incontinence
13. Americas Mirabegron Sustained-release Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Mirabegron Sustained-release Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Mirabegron Sustained-release Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Astellas Pharma Inc.
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Viatris Inc.
16.3.4. Sandoz International GmbH
16.3.5. Dr. Reddy’s Laboratories Ltd.
16.3.6. Amneal Pharmaceuticals LLC
16.3.7. Sun Pharmaceutical Industries Ltd.
16.3.8. Cipla Ltd.
16.3.9. Lupin Limited
16.3.10. Torrent Pharmaceuticals Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET: RESEARCHAI
FIGURE 26. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 25 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ORIGINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ORIGINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY URGE INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY URGE INCONTINENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 88. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 89. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 98. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 99. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 102. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 103. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 174. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 175. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 180. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 181. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 185. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. GERMANY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 199. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. FRANCE MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 216. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 217. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 226. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 227. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. ITALY MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 241. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. SPAIN MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. DENMARK MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. DENMARK MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. DENMARK MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK MIRABEGRON SUSTAINED-RELEASE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. DENMARK MIRABEGRON S

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mirabegron Sustained-release Tablets market report include:
  • Astellas Pharma Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • Amneal Pharmaceuticals LLC
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Lupin Limited
  • Torrent Pharmaceuticals Ltd.

Related Topics

Related Reports

Mirabegron Drugs Market - Global Forecast 2025-2030 - Product Image

Mirabegron Drugs Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report - Product Image

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Overactive Bladder Treatment Market Report and Forecast 2025-2034 - Product Image

Overactive Bladder Treatment Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Urinary Incontinence Drugs Market Report and Forecast 2025-2034 - Product Image

Urinary Incontinence Drugs Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Overactive Bladder Treatment Market - Global Forecast 2025-2032 - Product Image

Overactive Bladder Treatment Market - Global Forecast 2025-2032

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.